Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress

Go back to Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress
(NASDAQ: AUPH) Delayed: 16.07 -0.01 (0.06%)
Previous Close $16.08    52 Week High $5.69 
Open $15.98    52 Week Low $1.42 
Day High $16.38    P/E N/A 
Day Low $15.93    EPS $0.00 
Volume 970,278